These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 8470031
1. [Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia]. Maldonado MS, Otheo de Tejada E, Muñoz Villa A, García Laraña J. Sangre (Barc); 1993 Feb; 38(1):13-6. PubMed ID: 8470031 [Abstract] [Full Text] [Related]
2. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related]
3. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G. Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375 [Abstract] [Full Text] [Related]
4. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G. Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531 [Abstract] [Full Text] [Related]
5. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
7. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission. Torres A, Martínez F, Gómez P, Fornés G, Rojas R, Herrera C, Gómez JL, Manzanares R, García JM, Andres P. Bone Marrow Transplant; 1989 Nov; 4(6):609-12. PubMed ID: 2819281 [Abstract] [Full Text] [Related]
8. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia]. Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J. Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472 [Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia. Sharathkumar A, Saunders EF, Dror Y, Grant R, Greenberg M, Weitzman S, Chan H, Calderwood S, Freedman MH, Doyle J. Bone Marrow Transplant; 2004 Jan 15; 33(1):39-45. PubMed ID: 14566329 [Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Bone Marrow Transplant; 1996 Feb 15; 17(2):191-6. PubMed ID: 8640165 [Abstract] [Full Text] [Related]
11. Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias. Suttorp M, Schmitz N, Leuschner S, Appelt M, Rister M, Schaub J. Bone Marrow Transplant; 1989 Dec 15; 4 Suppl 4():144-8. PubMed ID: 2697428 [Abstract] [Full Text] [Related]
12. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL. Bone Marrow Transplant; 1996 May 15; 17(5):763-8. PubMed ID: 8733695 [Abstract] [Full Text] [Related]
13. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb 15; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related]
14. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T, Kojima S, Kato K. Bone Marrow Transplant; 1998 Jul 15; 22(1):21-6. PubMed ID: 9678791 [Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle. von Bueltzingsloewen A, Esperou-Bourdeau H, Souillet G, Demeocq F, Mechinaud-Lacroix F, Michel G, Sadoun A, Bernaudin F, Cornu G, Donadieu J. Bone Marrow Transplant; 1995 Oct 15; 16(4):521-7. PubMed ID: 8528167 [Abstract] [Full Text] [Related]
16. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Stockschläder M, Hegewisch-Becker S, Krüger W, tom Dieck A, Mross K, Hoffknecht M, Berger C, Kohlschütter B, Martin H, Peters S. Bone Marrow Transplant; 1995 Nov 15; 16(5):663-7. PubMed ID: 8547863 [Abstract] [Full Text] [Related]
17. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct 15; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related]
18. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P. Haematologica; 2000 Nov 15; 85(11 Suppl):47-53. PubMed ID: 11268324 [Abstract] [Full Text] [Related]
19. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma. Bernard M, Dauriac C, Drénou B, Leberre C, Branger B, Fauchet R, Le Prisé PY, Lamy T. Bone Marrow Transplant; 1999 Feb 15; 23(4):329-33. PubMed ID: 10100576 [Abstract] [Full Text] [Related]
20. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A. J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]